Advertisement

Journal of Business Ethics

, Volume 83, Issue 4, pp 745–758 | Cite as

Corporate Social Responsibility (CSR): Models and Theories in Stakeholder Dialogue

  • Linda O’Riordan
  • Jenny FairbrassEmail author
Article

Abstract

The pharmaceutical sector, an industry already facing stiff challenges in the form of intensified competition and strategic consolidation, has increasingly become subject to a range of pressures. Crucially, in common with other large-scale businesses, pharmaceutical firms find themselves ‹invited’ to respond positively to the corporate ‹social’ responsibility (CSR) expectations of their stakeholders. Consequently, individual managers will almost certainly be obliged to engage in some form of stakeholder dialogue and this, in turn, means that they will have to make difficult choices about which practices to adopt. This real-world management predicament runs parallel to an academic interest in CSR stakeholder dialogue theory and models. Accordingly, the approach of this paper is to focus primarily on the academic debate surrounding stakeholder dialogue, by reviewing past attempts to research and theorise the subject, by identifying gaps and weaknesses in the literature, and by proposing a new analytical model. The central aim of the proposed new model is to offer a unified, structured, systematic, and comprehensive approach to CSR decision making whilst simultaneously providing a practical framework for CSR executives who face the challenge of responding in an effective manner to stakeholders. The model outlined here is currently being employed to conduct international comparative empirical research into stakeholder dialogue practices amongst UK and German pharmaceutical firms. In the longer term the intention is to use the model to undertake international comparative research encompassing a broader range of countries and industries.

Keywords

corporate social responsibility pharmaceutical industry stakeholders stakeholder dialogue 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acutt J. N., Medina-Ross V., O’Riordan T.: 2004, Perspectives on Corporate Social Responsibility in the Chemical Sector: A Comparative Analysis of the Mexican and South African cases, Natural Resources Forum, 28, 302–316CrossRefGoogle Scholar
  2. Baker, M.: 2004, ‹Emerging Issues in CSR – Drugs for AIDS in Africa’, www.mallenbaker.net/csr/CSRfiles/aids.html, accessed 5th October 2004
  3. Blum-Kusterer M., Hussain S. S.: 2001, Innovation and Corporate Sustainability: An Investigation into the Process of Change in the Pharmaceuticals Industry, Business Strategy and the Environment. 10(5), 300–316CrossRefGoogle Scholar
  4. Bowmann-Larsen L., Wiggen O.: 2004, Responsibility in World Business: Managing Harmful Side-Effects of Corporate Activity, USA: United Nations University PressGoogle Scholar
  5. Brammer S., Pavelin S.: 2004, Building a Good Reputation, European Management Journal, 22(6), 704–713CrossRefGoogle Scholar
  6. Burke L., Logsdon J. M.: 1996, How Corporate Social Responsibility Pays Off, Long Range Planning 29(4), 495–502CrossRefGoogle Scholar
  7. Business and Human Rights: 2003, ‹Business and Human Rights Dilemmas and Solutions’, in R. Sullivan (ed.), Insight Investment UK, with a Forward by Mary Robinson (www.duurzaam-ondernemen.nl, accessed 8th March 2005)
  8. Carroll A. B.: 1999, Corporate Social Responsibility: The Evolution of a Definitional Construct, Business and Society 38(3), 268–295CrossRefGoogle Scholar
  9. Carroll A., G. Beiler: 1978, Landmarks in the Evolution of the Social Audit in A. Carroll (ed.), Managing Corporate Social Responsibility (Boston, Little, Brown and Co.)Google Scholar
  10. Castka P. et al: 2004, How Can SMEs Effectively Implement the CSR Agenda? A UK Case Study Perspective, Corporate Social Responsibility and Environmental Management, 11, 140–149CrossRefGoogle Scholar
  11. Challen P.: 1974, Corporate Planning for Social Responsibility, Long Range Planning, 38, 44Google Scholar
  12. Clark C.: 2000, Differences Between Public Relations and Corporate Social Responsibility: An Analysis, Public Relations Review 26(3), 363–380CrossRefGoogle Scholar
  13. Crane A., Matten D.: 2004, Business Ethics: A European Perspective. (NY, USA: Oxford University Press)Google Scholar
  14. Cropanzano R. et al: 2004, Accountability for Injustice, Human Resource Management Review, 14, 107–133CrossRefGoogle Scholar
  15. CSR Risk Mapping Initiative: 2004, ‹Human Rights and Business Risk in the Pharmaceutical and Chemical Sectors’, www.iblf.org/csr/csrwebassist.nsf/webprintview/blf2d3.html, accessed 7th October 2004
  16. Daniels J., Radebaugh L.: 2001, International Business: Environments and Operations, (New Jersey: Prentice Hall Inc.)Google Scholar
  17. Deresky H. (2000) International Management: Managing Across Boarders and Cultures. (New Jersey: Prentice Hall Inc.)Google Scholar
  18. Epstein M, Roy M.: 2001, Sustainability in Action: Identifying and Measuring the Key Performance Drivers, Long Range Planning 34, 585–604CrossRefGoogle Scholar
  19. Esrock S. L., Leichty G. B.: 1998, Social Responsibility and Corporate Web Pages: Self-Presentation or Agenda-Setting? Public Relations Review, 24(3), 305–319CrossRefGoogle Scholar
  20. Fairbrass, J.: 2006, ‹UK Businesses and CSR Policy: Shaping the Debate in the EU’, Working Paper 06/31, School of Management, University of Bradford. October 2006Google Scholar
  21. Fairbrass, J.: 2008, ‹Corporate Social Responsibility in Europe: The EU and National Policy Models Compared’, Working Paper 08/03, School of Management, University of Bradford, February 2008Google Scholar
  22. Fairbrass, J., L. O’Riordan and H. Mirza: 2006, ‹Corporate Social Responsibility: Differing Definitions and Practices?’, Working Paper 06/05, School of Management, University of Bradford, February 2006Google Scholar
  23. Freeman R. E.: 1984, Strategic Management: A stakeholder Approach, (Massachusetts: Pitman Publishing Inc.)Google Scholar
  24. Get Ethical-Ethical Matters: 2004, ‹Hot Topics – GlaxoSmithKline’, www.ethicalmatters.co.uk/articles.asp?itemID=181, accessed 15th October 2004
  25. Gladwell M.: 2005, The Tipping Point: How Little Thinks Can Make a Big Difference (London: Abacus)Google Scholar
  26. Greenfield W. M.: 2004, In the Name of Corporate Social Responsibility, Business Horizons 47(1), 19–28CrossRefGoogle Scholar
  27. Habisch A., Jonker J.: 2005, Corporate Social Responsibility (Berlin, Germany: Springer Verlag)Google Scholar
  28. Handy, C.: 2003, ‹What’s Business for’, in Harvard Business Review on Corporate Responsibility (harvard Business School Publishing Corporation, USA)Google Scholar
  29. Haugh R.: 2003, Getting the Attention of Big Pharma, Hospitals & Health Networks, 77(10), 44Google Scholar
  30. Hoertz Badaracco C.: 1998, The Transparent Corporation and Organized Community Public Relations Review, 24(3), 265–272CrossRefGoogle Scholar
  31. Hofstede G.: 1997, Cultures and Organisations: Software of the Mind – Intercultural Cooperation and its Importance for Survival (New York, USA: McGraw-Hill)Google Scholar
  32. Knoepfel I. 2001, Dow Jones Sustainability Group Index: A Global Benchmark for Corporate Sustainability, Corporate Environmental Strategy, 8(1), 6–15CrossRefGoogle Scholar
  33. Kotler P., Lee N.: 2005, Corporate Social Responsibility: Doing the Most Good for Your Company and Your Cause (New Jersey: John Wiley and SonsGoogle Scholar
  34. Maignan I., Ferrell O.: 2003, Nature of Corporate Responsibilities: Perspectives from American, French, and German Consumers, Journal of Business Research, 56, 55–67CrossRefGoogle Scholar
  35. Maignan I., et al: 2002, Managing Socially Responsible Buying: How to Integrate Non-Economic Criteria into the Purchasing Process, European Management Journal 20(6), 641–648CrossRefGoogle Scholar
  36. Murray K. B., Vogel C. M.: 1997, Using a Hierarchy-of Effects Approach to Gauge the Effectiveness of Corporate Social Responsibility to Generate Goodwill Toward the Firm: Financial Versus Non Financial Impacts, Journal of Business Research 38, 141–159CrossRefGoogle Scholar
  37. Newsaic: 2001, ‹Worldwide Incidence and Prevalence Rates’, www.newsaic.com/mwaids.html, accessed 15th October 2004
  38. O’Higgins E.: 2005, Ireland: Bridging the Atlantic in A. Habisch, J. Jonker (Eds.), Corporate Social Responsibility, (Berlin, Germany: Springer Verlag)Google Scholar
  39. O’Riordan, L.: 2006, CSR and Stakeholder Dialogue: Theory, Concepts, and Models for the Pharmaceutical Industry (MRes Dissertation, University of Bradford, Bradford)Google Scholar
  40. O’Riordan, L. and J. Fairbrass: 2006, ‹Corporate Social Responsibility (CSR). Models and Theories in Stakeholder Dialogue’, Working Paper 06/45, School of Management, University of Bradford, November 2006Google Scholar
  41. Oxfam/VSO/Save the Children: 2002, Beyond Philanthropy: The Pharmaceutical Industry, Corporate Social Responsibility and the Developing World (London)Google Scholar
  42. Porter M. E.: 1985, Competitive Advantage: Creating and Sustaining Superior Performance. (New York, USA: Free Press Edition)Google Scholar
  43. PriceWaterhouseCoopers: 2006, ‹Corporate Responsibility in the Pharmaceutical Industry’, www.pwc.com/servlet/PWCPrintPteview, accessed 19th May 2004
  44. Quist-Arcton, O.: 2001, ‹Drugs Giants Drop Case Against South Africa’, AllAfrica.com, Johannesburg, http://allafrica.comstories/printable/200104190053.html
  45. Ruggie, J.: 2003, ‹The New World of Corporate Social Responsibility’, www.ksg.harvard.edu/cbg/CSRI/publications/ruggie_new_world_of_csr.pdf
  46. Saravanamuthu K.: 2001, What is Measured Counts: Harmonized Corporate Reporting and Sustainable Economic Development, Critical Perspectives on Accounting, 15, 295–302CrossRefGoogle Scholar
  47. Stigson, B.: 2002, ‹Corporate Social Responsibility: A New Business Paradigm’, www.isuma.net/v03n02/stigson_e.shtml
  48. Sturdivant F.: 1977, Business and Society, (Homewood: R.D. Irwin Inc.)Google Scholar
  49. Teoh H., Thong G.: 1984, Another Look at Corporate Social Responsibility and Reporting: An Empirical Study in a Developing Country Accounting Organisations and Society, 9(2), 189–206CrossRefGoogle Scholar
  50. Third World Network: 2004, ‹Third World Network: Aids Activists March Against Pharmaceutical Companies’, www.twnside.org.sg/title/against.htm, accessed 15th October 2004
  51. Trompenaars F., Hampden-Turner C.: 2004, Riding the Waves of Culture: Understanding Cultural Diversity in Business, 3rd Edition (London: Nicholas Brealey Publishing)Google Scholar
  52. Veleva V., et al: 2003, Indicators for Measuring Environmental Sustainability: A Case Study of the Pharmaceutical Industry, Benchmarking: An International Journal, 10(2), 107–119CrossRefGoogle Scholar
  53. WBCSD: 2002, The Business Case for Sustainable Development: Making a Difference Towards the Johannesburg Summit 2002 and Beyond (World Business Council for Sustainable Development, Geneva, Switzerland)Google Scholar
  54. Weiss J. W.: 1998, Business Ethics: A stakeholder and Issues Management Approach, Forth Worth, USA: Dryden PressGoogle Scholar
  55. Welford, R.: 2004, ‹Corporate Social Responsibility in Europe and Asia: Critical Elements and Best Practice’, Journal of Corporate Citizenship 13, 31–48Google Scholar
  56. Welford, R.: 2005, ‹Corporate Social Responsibility in Europe, North America and Asia’, Journal of Corporate Citizenship 17, 33–52Google Scholar
  57. Woodward D. et al: 2001, “Some Evidence on Executives”. Views of Corporate Social Responsibility, British Accounting Review 33, 357–397CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.School of ManagementUniversity of BradfordBradfordU.K.

Personalised recommendations